Natasha Giordano

Insider Reports History

Entity
Individual
Location
8285 El Rio Street, Suite 130, Houston, TX
Signature
/s/ Keith A. Kucinski, attorney-in fact for Natasha Giordano
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Natasha Giordano:

Stock Role Class Num Shares Value Price $ Report Date Ownership
PLx Pharma Inc. Chief Executive Officer, Director Common Stock 5.19K $18.9K $3.65 Mar 15, 2022 Direct
Matinas BioPharma Holdings, Inc. Director Stock option (right to buy) 437K Nov 1, 2023 Direct
PLx Pharma Inc. Chief Executive Officer, Director Stock Option (right to buy) 300K Feb 22, 2022 Direct

Insider Reports Filed by Natasha Giordano

Symbol Company Period Transactions Value $ Form Type Date Filed Role
MTNB Matinas BioPharma Holdings, Inc. Nov 1, 2023 1 $0 4 Nov 3, 2023 Director
MTNB Matinas BioPharma Holdings, Inc. Nov 14, 2022 1 $0 4 Nov 16, 2022 Director
PLXPQ PLx Pharma Inc. Mar 15, 2022 1 $15K 4 Mar 16, 2022 Chief Executive Officer, Director
PLXPQ PLx Pharma Inc. Feb 22, 2022 1 $0 4 Feb 24, 2022 Chief Executive Officer, Director
MTNB Matinas BioPharma Holdings, Inc. Nov 1, 2021 1 $0 4 Nov 2, 2021 Director
PLXPQ PLx Pharma Inc. Aug 9, 2021 1 $0 4 Aug 11, 2021 Chief Executive Officer, Director